PillRx only · Tablet · Oral
Hydrocodone Bitartrate And Homatropine Methylbromide
Homatropine Methylbromide + Hydrocodone Bitartrate
4 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US4 NDCs
4 active makers
4 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 4 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$0.940
Latest avg · Jul 22, 2026
-1%
Since Dec 17, 2025
4
Active US suppliers
64%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
34
Rx · 2025 Q4
866
Units dispensed
3
Quarters · since 2025 Q1
Who makes it4 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| KVK-TECH, Inc. | unknown | 4 | SUPPLYING |
| Novel Laboratories, Inc. | unknown | 3 | SUPPLYING |
| Lupin Pharmaceuticals,Inc. | unknown | 2 | SUPPLYING |
| Genus Lifesciences | unknown | 2 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Apr 27, 2021RECALLRecall (Class III): Hydrocodone Bitartrate and Homatropine Methlybromide tablets, USP, 5 mg/ 1.5 mg, 30-count bottle, Rx only, Mfd. By:KVK-…
Failed Impurities/Degradation Specifications — Recalling firm: KVK-Tech, Inc. — Distributed Nationwide in the USA
- Mar 5, 2018RECALLRecall (Class III): Lupin Hydrocodone Bitartrate and Homatropine Methylbromide Tablets, USP 5/1.5 mg Rx Only 30 Tablets Manufactured by: No…
Failed Impurities/Degradation Specifications — Recalling firm: Novel Laboratories, Inc. — Nationwide